Cytori Therapeutics, Inc. (CYTX) Reports Larger Q3 Loss
Tweet
Share
E-mailGet Alerts CYTX Hot Sheet
Price: $0.21 --0%
Financial Fact:
Other income (expense), net: -696K
Today's EPS Names:
CHA, EDXC, YAYO, More
Financial Fact:
Other income (expense), net: -696K
Today's EPS Names:
CHA, EDXC, YAYO, More
Join SI Premium – FREE
Cytori Therapeutics, Inc. (NASDAQ: CYTX) reported Q1 EPS of ($0.23), $0.08 worse than the analyst estimate of ($0.15). Revenue for the quarter came in at $1.36 million versus the consensus estimate of $3.21 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- The Gap, Inc. (GAP) Tops Q2 EPS by 3c
- NVIDIA (NVDA) Tops Q2 EPS by 14c, Offers Guidance
- GSX Techedu Inc. (GOTU) Misses Q2 EPS by 11c; offers guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
